Currently out of the existing stock ratings of Keyur Parekh, 4 are a HOLD (36.36%), 7 are a BUY (63.64%).

Keyur Parekh

Work Performance Price Targets & Ratings Chart

Analyst Keyur Parekh, carries an average stock price target met ratio of 60% that have a potential upside of 38.34% achieved within 731 days. Previously, Keyur Parekh worked at GOLDMAN SACHS.

Keyur Parekh’s has documented 19 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Feb-2023.

Wall Street Analyst Keyur Parekh

Analyst best performing recommendations are on DBVT (DBV TECHNOLOGIES).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/26/2022. The price target of $60.58 was fulfilled within 316 days with a profit of $17 (39.01%) receiving and performance score of 1.23.

Average potential price target upside

of $44.9 (71.3%) on NVS (NOVARTIS AG ADR).
of $14.57 (44.03%) on NVO (NOVO NORDISK A/S).

AZN AstraZeneca PLC ADR NVS Novartis AG ADR SNY Sanofi ADR NVO Novo Nordisk A/S GSK GlaxoSmithKline PLC ADR DBVT DBV Technologies ZEAL Zealand Pharma A/S ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Steve Scala (TD COWEN)